FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2466393631> ?p ?o ?g. }

• W2466393631 endingPage "723" @default.
• W2466393631 startingPage "715" @default.
• W2466393631 abstract "Proper qualification of patients with cancer for an effective treatment regiment is essential to rationalize therapy benefit and costs. The early detection of genetic disorders that are responsible for the stimulation of uncontrolled cancer cells proliferation makes it possible to select a group of patients with a high probability of response to molecularly-targeted therapy. Data has shown that careful analysis of genes mutation using different PCR and sequencing techniques or chromosomal aberrations using in situ hybridization (ISH) techniques have a predictive value for drug targeted therapy. Overexpression of receptors and gene amplification has been reported in various cancers. Their detection is still a considerable challenge, which is connected with the unsatisfactory quality of DNA and low mutated cells percentage compared to cells with no genetic abnormalities in tested material. Different techniques of standardization were performed to prevent false negative results and to increase the sensitivity of qualitative and quantitative evaluation of chromosomal abnormalities. Immunohistochemistry (IHC) technique is useful in the screening of receptor expression in paraffin-embedded tissue samples in different malignant diseases. Whereas ISH techniques, especially fluorescence in situ hybridization (FISH), are now considered the diagnostic gold standard method in detection chromosomal aberrations. Moreover, molecular biology techniques, which are using molecular probes and real-time PCR and quantitative PCR techniques, were also applied for the detection of chromosomal changes. In order to identify the best genetic marker for treatment regiment, it is important to compare results of different studies, which are evaluating the sensitivity of diagnostic techniques and treatment response after a suitable selection factors based on genetic aberrations profile." @default.
• W2466393631 created "2016-07-22" @default.
• W2466393631 creator A5023250116 @default.
• W2466393631 creator A5051885027 @default.
• W2466393631 creator A5079664149 @default.
• W2466393631 creator A5087508872 @default.
• W2466393631 date "2015-01-01" @default.
• W2466393631 modified "2023-10-16" @default.
• W2466393631 title "Detection of Chromosomal Abnormalities with Different In Situ Hybridisation Techniques - the Usefulness in Cancer Patients Qualification for Molecularly-Targeted Therapies" @default.
• W2466393631 cites W1481640416 @default.
• W2466393631 cites W1594510878 @default.
• W2466393631 cites W1840508780 @default.
• W2466393631 cites W1970476748 @default.
• W2466393631 cites W1979846448 @default.
• W2466393631 cites W1982547746 @default.
• W2466393631 cites W1986552598 @default.
• W2466393631 cites W1987009448 @default.
• W2466393631 cites W1991184965 @default.
• W2466393631 cites W1994622652 @default.
• W2466393631 cites W1997656925 @default.
• W2466393631 cites W2005855388 @default.
• W2466393631 cites W2007894352 @default.
• W2466393631 cites W2018922262 @default.
• W2466393631 cites W2021053102 @default.
• W2466393631 cites W2029367320 @default.
• W2466393631 cites W2031473726 @default.
• W2466393631 cites W2032861637 @default.
• W2466393631 cites W2037401581 @default.
• W2466393631 cites W2039407184 @default.
• W2466393631 cites W2044433401 @default.
• W2466393631 cites W2051740910 @default.
• W2466393631 cites W2075324183 @default.
• W2466393631 cites W2077409585 @default.
• W2466393631 cites W2100439220 @default.
• W2466393631 cites W2102735352 @default.
• W2466393631 cites W2106197862 @default.
• W2466393631 cites W2106787323 @default.
• W2466393631 cites W2118112346 @default.
• W2466393631 cites W2120906949 @default.
• W2466393631 cites W2122553809 @default.
• W2466393631 cites W2125920781 @default.
• W2466393631 cites W2130488043 @default.
• W2466393631 cites W2133441588 @default.
• W2466393631 cites W2135192471 @default.
• W2466393631 cites W2138523273 @default.
• W2466393631 cites W2148332636 @default.
• W2466393631 cites W2150461324 @default.
• W2466393631 cites W2151640153 @default.
• W2466393631 cites W2159081821 @default.
• W2466393631 cites W2159399172 @default.
• W2466393631 cites W2159967578 @default.
• W2466393631 cites W2161708183 @default.
• W2466393631 cites W2165651085 @default.
• W2466393631 cites W2166199281 @default.
• W2466393631 doi "https://doi.org/10.17219/acem/28825" @default.
• W2466393631 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26469118" @default.
• W2466393631 hasPublicationYear "2015" @default.
• W2466393631 type Work @default.
• W2466393631 sameAs 2466393631 @default.
• W2466393631 citedByCount "0" @default.
• W2466393631 crossrefType "journal-article" @default.
• W2466393631 hasAuthorship W2466393631A5023250116 @default.
• W2466393631 hasAuthorship W2466393631A5051885027 @default.
• W2466393631 hasAuthorship W2466393631A5079664149 @default.
• W2466393631 hasAuthorship W2466393631A5087508872 @default.
• W2466393631 hasBestOaLocation W24663936311 @default.
• W2466393631 hasConcept C104317684 @default.
• W2466393631 hasConcept C121608353 @default.
• W2466393631 hasConcept C126322002 @default.
• W2466393631 hasConcept C142724271 @default.
• W2466393631 hasConcept C150194340 @default.
• W2466393631 hasConcept C2777542201 @default.
• W2466393631 hasConcept C2781230642 @default.
• W2466393631 hasConcept C30481170 @default.
• W2466393631 hasConcept C40993552 @default.
• W2466393631 hasConcept C502942594 @default.
• W2466393631 hasConcept C54355233 @default.
• W2466393631 hasConcept C70721500 @default.
• W2466393631 hasConcept C71924100 @default.
• W2466393631 hasConcept C7602840 @default.
• W2466393631 hasConcept C81439078 @default.
• W2466393631 hasConcept C86803240 @default.
• W2466393631 hasConceptScore W2466393631C104317684 @default.
• W2466393631 hasConceptScore W2466393631C121608353 @default.
• W2466393631 hasConceptScore W2466393631C126322002 @default.
• W2466393631 hasConceptScore W2466393631C142724271 @default.
• W2466393631 hasConceptScore W2466393631C150194340 @default.
• W2466393631 hasConceptScore W2466393631C2777542201 @default.
• W2466393631 hasConceptScore W2466393631C2781230642 @default.
• W2466393631 hasConceptScore W2466393631C30481170 @default.
• W2466393631 hasConceptScore W2466393631C40993552 @default.
• W2466393631 hasConceptScore W2466393631C502942594 @default.
• W2466393631 hasConceptScore W2466393631C54355233 @default.
• W2466393631 hasConceptScore W2466393631C70721500 @default.
• W2466393631 hasConceptScore W2466393631C71924100 @default.
• W2466393631 hasConceptScore W2466393631C7602840 @default.
• W2466393631 hasConceptScore W2466393631C81439078 @default.
• W2466393631 hasConceptScore W2466393631C86803240 @default.

• next